clinical decision support developers

Abstract: Background: Microvascular invasion (MVI) predicts recurrence and survival in hepatocellular carcinoma (HCC) but requires postoperative histopathology for diagnosis. We developed and validated a model integrating multimodal ultrasound and clinical data for preoperative MVI prediction. Methods: This multicenter study included 489 patients with HCC from eight centers. All patients had B-mode ultrasound (BUS), color Doppler flow imaging (CDFI), dynamic contrast-enhanced ultrasound (DCE-US), and clinical information. Data from seven centers (n = 421) were used for model development with five-fold cross-validation; data from the remaining center (n = 68) formed an independent external validation cohort. The proposed multimodal information fusion network used modality-specific encoders, a hemodynamic temporal change module for bidirectional DCE-US perfusion changes, and a representation consistency learning module to align heterogeneous ultrasound representations before Transformer-based fusion. Results: In external validation, DCE-US achieved the highest single-modality area under the receiver operating characteristic curve (AUC; 0.8545+/-0.0198), versus clinical information (0.6715+/-0.0156), CDFI (0.6435+/-0.0344), and BUS (0.6087+/-0.0417). Pixel-difference sampling and the proposed temporal module outperformed alternative sampling and video representation methods. The full model achieved the best performance, with an AUC of 0.8953+/-0.0180, accuracy of 81.18%+/-2.83%, sensitivity of 86.40%+/-6.69%, and specificity of 78.14%+/-6.28. Conclusions: Integrating multimodal ultrasound and clinical information enabled promising preoperative MVI prediction in HCC. DCE-US was the main source of predictive information, while BUS, CDFI, and clinical information provided complementary value. The proposed framework may support preoperative risk stratification and individualized clinical decision-making.

Abstract: Multi-label few-shot learning (MLFSL) remains a significant challenge in medical image analysis (MIA). Current metric-based meta-learning methods face two critical limitations in MIA. First, conventional prototype generation often entangles irrelevant disease information, leading to contaminated prototypes and degraded performance. Second, prior studies typically enforce inter-class separability in embedding space, largely neglecting the inherent correlations among diseases. To overcome these challenges, we propose Prototype Purification and Regulation (PPR), a novel MLFSL framework for MIA. PPR first performs prototype purification by leveraging sample-level comorbidity scores to emphasize disease-specific features, producing purified prototypes that better characterize each disease. Building upon these purified prototypes, PPR further addresses the underexplored problem of inter-class prototype distance in MIA by incorporating disease-level comorbidity statistics to adaptively regulate inter-class similarity, forming a comorbidity-aware embedding space. Overall, PPR sequentially enables the model to capture pure disease features and inter-class relationships for reliable MLFSL in MIA. Extensive experiments across four chest X-ray benchmark datasets, including cross-domain evaluation, show that PPR consistently outperforms state-of-the-art methods, significantly improving disease detection while demonstrating robust generalization and clinical applicability.

Abstract: Acute infectious diseases are among the leading causes of medical consultations and hospitalizations in children worldwide. These infections are predominantly caused by viruses or bacteria, yet differentiating between the two remains a common clinical challenge. As a result, pediatricians often default to the safer option of prescribing antibiotics contributing to the growing problem of antimicrobial resistance. The objective is to assess the additional predictive value of CBC towards determining the current infection. This retrospective study used data from 906 pediatric patients aged between 2 and 14 years who were tested positive either for viral or bacterial infection between 2022 and 2026. Inclusion criteria further required availability of CBC results and CRP level measurements. These laboratory parameters as well as age were used as input features for several supervised classification models. Model performance was evaluated using AUC, sensitivity and specificity. The best performing model is XGBoost, which included all features, achieving out of-sample performance of AUC of 81.7% and sensitivity of 70.8%, specificity of 79.2%. All trained models outperform a CRP-based only decision-rule model in terms of AUC. We suggest that the decision to prescribe antibiotics should be based on a number of factors, including but not limited to CBC, some of which are not currently incorporated into routine practice.